Skip to main content
Premium Trial:

Request an Annual Quote

JGI, IU Scentists Complete Water Flea Shotgun Sequence

NEW YORK, Jan. 19 (GenomeWeb News) - Scientists from the Joint Genome Institute and Indiana University have completed a shotgun sequence for Daphnia pulex, also known as the water flea.


The announcement was made yesterday at the annual meeting of the Daphnia Genomics Consortium in Bloomington, Indiana.


Daphnia is the first crustacean genome to be sequenced. It has 200 million base pairs on 12 pairs of chromosomes. Scientists said they sequenced it eight times and will post their findings in a database here.


The sequence could contribute to scientific understanding of the effect of the environment on genetics by "allowing us to infer the ground state from which the insect genomes evolved," Jeffrey Boone, JGI's head of evolutionary genomics, said in a statement.


Most of the sequencing work was done at DOE JGI's facility in Walnut Creek, Calif. It was funded by both DOE JGI and the National Science Foundation.


The Daphnia Genomics Consortium was organized in October 2002.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.